These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36722904)

  • 41. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
    Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
    PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.
    Lustberg MB; Balasubramanian P; Miller B; Garcia-Villa A; Deighan C; Wu Y; Carothers S; Berger M; Ramaswamy B; Macrae ER; Wesolowski R; Layman RM; Mrozek E; Pan X; Summers TA; Shapiro CL; Chalmers JJ
    Breast Cancer Res; 2014 Mar; 16(2):R23. PubMed ID: 24602188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correction: A multifunctional black phosphorus nanosheet-based immunomagnetic bio-interface for heterogeneous circulating tumor cell capture and simultaneous self-identification in gastric cancer patients.
    Zuo Y; Xia Y; Lu W; Li Y; Xiao Y; Gao S; Zhou Z; Xu H; Feng X; Li C; Yu Y
    Nanoscale; 2024 Dec; 16(47):22047. PubMed ID: 39569556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs).
    Myung JH; Launiere CA; Eddington DT; Hong S
    Langmuir; 2010 Jun; 26(11):8589-96. PubMed ID: 20155985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model.
    Muhanna N; Mepham A; Mohamadi RM; Chan H; Khan T; Akens M; Besant JD; Irish J; Kelley SO
    Nanomedicine; 2015 Oct; 11(7):1613-20. PubMed ID: 25981337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical utility of non-EpCAM based circulating tumor cell assays.
    Austin RG; Huang TJ; Wu M; Armstrong AJ; Zhang T
    Adv Drug Deliv Rev; 2018 Feb; 125():132-142. PubMed ID: 29366804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multicomponent nanosystem for capturing circulating tumor cells from cancer patients with PD-L1 as an immunotherapy oncotarget.
    Khutale G; Andhari S; Gupta R; Aland G; Banerjee S; Todkar K; Pore M; Khobragade V; D'Souza A; Kale N; Vasudevan A; Bharde A; Jayant S; Patil Y; Khandare J
    J Mater Chem B; 2024 Oct; 12(42):10973-10982. PubMed ID: 39348156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of novel markers that outperform EpCAM in quantifying circulating tumor cells.
    Kim MJ; Choi NY; Lee EK; Kang MS
    Cell Oncol (Dordr); 2014 Aug; 37(4):235-43. PubMed ID: 25001871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads.
    Kim YJ; Koo GB; Lee JY; Moon HS; Kim DG; Lee DG; Lee JY; Oh JH; Park JM; Kim MS; Woo HG; Kim SI; Kang P; Choi W; Sim TS; Park WY; Lee JG; Kim YS
    Biomaterials; 2014 Aug; 35(26):7501-10. PubMed ID: 24917030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quick-response magnetic nanospheres for rapid, efficient capture and sensitive detection of circulating tumor cells.
    Wen CY; Wu LL; Zhang ZL; Liu YL; Wei SZ; Hu J; Tang M; Sun EZ; Gong YP; Yu J; Pang DW
    ACS Nano; 2014 Jan; 8(1):941-9. PubMed ID: 24313365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
    Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
    Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer.
    Brungs D; Lynch D; Luk AW; Minaei E; Ranson M; Aghmesheh M; Vine KL; Carolan M; Jaber M; de Souza P; Becker TM
    World J Gastroenterol; 2018 Feb; 24(7):810-818. PubMed ID: 29467551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nano "fly paper" technology for the capture of circulating tumor cells.
    Wang S; Owens GE; Tseng HR
    Methods Mol Biol; 2011; 726():141-50. PubMed ID: 21424448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM
    Lampignano R; Yang L; Neumann MHD; Franken A; Fehm T; Niederacher D; Neubauer H
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles.
    Wang G; Benasutti H; Jones JF; Shi G; Benchimol M; Pingle S; Kesari S; Yeh Y; Hsieh LE; Liu YT; Elias A; Simberg D
    Colloids Surf B Biointerfaces; 2018 Jan; 161():200-209. PubMed ID: 29080504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs).
    Hyun KA; Lee TY; Lee SH; Jung HI
    Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation.
    Vila A; Abal M; Muinelo-Romay L; Rodriguez-Abreu C; Rivas J; López-López R; Costa C
    PLoS One; 2016; 11(10):e0163705. PubMed ID: 27711186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vertical Magnetic Separation of Circulating Tumor Cells for Somatic Genomic-Alteration Analysis in Lung Cancer Patients.
    Yoo CE; Park JM; Moon HS; Joung JG; Son DS; Jeon HJ; Kim YJ; Han KY; Sun JM; Park K; Park D; Park WY
    Sci Rep; 2016 Nov; 6():37392. PubMed ID: 27892470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The construction of EpCAM/vimentin-PLGA/lipid immunomagnetic microspheres and the isolation of circulating tumor cells from lung cancer.
    Li G; Wang Y; Tan G
    Int J Clin Exp Pathol; 2018; 11(12):5561-5570. PubMed ID: 31949643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.